Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intibios Lab is a prominent Indonesian healthcare service provider specializing in diagnostic laboratory services, clinical care, and pharmacy operations. Established in 2020 during the COVID-19 pandemic, the company initially focused on expanding national testing capacity through PCR and antigen services. It has since evolved into a comprehensive health network offering medical check-ups, vaccinations, and specialized diagnostic testing across multiple cities in Indonesia. The company operates under PT Intibios Medika Sejahtera and was co-founded by former Indonesian Minister of Trade Enggartiasto Lukita along with a group of entrepreneurs and medical professionals. Intibios Lab emphasizes the integration of laboratory technology with accessible primary care to improve public health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intibios Lab.